Efficacy of stereotactic body radiotherapy in primary renal cell carcinoma
- Conditions
- Neoplasms
- Registration Number
- KCT0007835
- Lead Sponsor
- Asan Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 40
? A patient diagnosed with renal cell carcinoma of T1aN0M0 (size 4 cm or less) by imaging examination.
? Patients who are difficult to apply surgical treatment due to one of the following conditions.
? Elderly patients aged 75 years or older
? Those with ECOG behavior level 2 or higher
? Those with a Charlson comorbidity index of 3 or higher.
? Those who refused surgical treatment.
? Those who agreed to the clinical trial
? Those who have not received systemic treatment for renal cell carcinoma
? Those who did not consent to the clinical trial.
? Those who have not performed the imaging test.
? Those with clinical stage T1b or higher.
? Those who have lymph nodes (N1) or distant metastases (M1) on imaging tests.
? Those who have undergone systemic treatment for renal cell carcinoma.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in tumor size
- Secondary Outcome Measures
Name Time Method kidney function